LULU vs TMO: Which Is the Better Buy?
Side-by-side comparison of Lululemon Athletica Inc. and Thermo Fisher Scientific Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-21.
Lululemon Athletica Inc. · Consumer Cyclical
$98.06
+1.5% upside to fair value
Low Conviction
Grade C
VS
Thermo Fisher Scientific Inc. · Healthcare
$658.32
+31.1% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
TMO has more upside to fair value
(+31.1%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
LULU |
TMO |
| Current Price |
$98.06 |
$658.32 |
| Fair Value Estimate |
$99.50 |
$863.34 |
| Upside to Fair Value |
+1.5%
|
+31.1%
|
| Market Cap |
$11.1B |
$244.7B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
4.6x
|
25.9x
|
| Price / Sales |
1.0x
|
5.3x
|
| Price / FCF |
8.2x
|
33.4x
|
| Revenue Growth YoY |
-4.3%
|
+10.5%
|
| Gross Margin |
56.1%
|
40.4%
|
| Operating Margin |
17.8%
|
17.7%
|
| Return on Equity |
29.7%
|
13.4%
|
| Dividend Yield |
0% |
0.28% |
| FCF Yield |
12.24%
|
3.0%
|
| Analyst Consensus |
Sell
|
Strong Buy
|
Investment Thesis
Lululemon Athletica designs and retails premium athletic apparel and accessories through company-owned stores and direct-to-consumer channels, with roughly 39,000 employees and a brand built on technical fabrics and community-led fitness positioning. The business still earns high returns on equity of 29.7% and generates $12.00 of free cash flow per share on $97.70 of revenue per share, with TTM g…
Thermo Fisher Scientific is a global life-sciences and laboratory-services platform spanning Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services, with recognized brands including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Patheon, and PPD, serving pharmaceutical, biotech, clinical, academic, and governme…
Accumulation Zones
| Metric |
LULU |
TMO |
| Zone Low |
$74.62 |
$647.50 |
| Zone High |
$84.58 |
$733.84 |
| In Buy Zone? |
No
|
Yes
|